References
- 1. Torbicki A, Perrier A, Konstantidines S et al. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2008; 29: 2276–315.
- 2. Bĕlohlávek J, Dytrych V, Linhart A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013; 18(2): 129–138.
- 3. Bricola SA, Paiva EF, Lichtenstein A et al. Fatal pulmonary embolism in hospitalized patients: a large autopsy-based matched case-control study. CLINICS 2013; 68(5): 679-685.10.6061/clinics/2013(05)16
- 4. Konstantinides SV. Trends in Pulmonary Embolism Outcomes. Are We Really Making Progress? (Editorial Comment). JACC 2016. 67 (2) 171-2.
- 5. Heit JA. Predicting the risk of venous thromboembolism recurrence. Am J Hematol 2012; 87 (S1): S63–S67.
- 6. Ferrer M, Morillo R, Elías T et al. Validation of two clinical prognostic models in patients with acute symptomatic pulmonary embolism. Arch Bronconeumol 2013; 49(10): 427–431.23664248
- 7. Konstantinides SV, Torbicki A, Agnelli G et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35: 3033–3069.
- 8. Di Marca S. Comparison of Wells and Revised Geneva Rule to Assess Pretest Probability of Pulmonary Embolism in High-Risk Hospitalized Elderly Adults. J Am Geriatr Soc. 2015; 63(6): 1091-7.
- 9. Shen JH, Chen HL, Chen JR, Xing JL, Gu P, Zhu BF. Comparison of the Wells score with the revised Geneva score for assessing suspected pulmonary embolism: a systematic review and meta-analysis. J Thromb Thrombolysis 2016 Apr; 41(3):482-92.26178041
- 10. Stein PD, Matta F, Musani MH, Diaczok B. Silent pulmonary embolism in patients with deep venous thrombosis: A systematic review. American Journal of Medicine. 2010; 123: 426-431.
- 11. Baglin T. What happens after venous thromboembolism? Rewiew. J Thromb Haemost 2009; (7)S1: 287-90.
- 12. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous Thromboembolism A Public Health Concern. Am J Prev Med 2010; 38(4S): 495–501.
- 13. Hsiao JF, Chu CM, Chung CM, Chang ST, Kuo CT and Hsu JT. Prognostic significance of thrombocytopenia in acute pulmonary embolism. J Intern Med Taiwan 2008; (19)6: 499–507.
- 14. Bhatt VR1, Aryal MR, Shrestha R, Armitage JO. Fondaparinux-associated heparin-induced thrombocytopenia. Eur J Haematol. 2013; 91(5): 437-41.
- 15. Warkentin TE, Pai M, Sheppard JI, Schulman S, Spyropoulos AC, Eikelboom JW. Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series. Thromb Haemost. 2011; 9(12): 2389-96.
- 16. Kitchens CS. Thrombocytopenia due to acute venous thromboembolism and it’s role in expanding the differential diagnosis of heparin-induced thrombocytopenia. Am J Hematol. 2004; 76(1): 69-73.
- 17. Kuijper EJ, Coignard BB, Teull PP. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12(Suppl 6): 2–18.